Nurix Therapeutics market cap NRIX
Share price times shares outstanding: what the whole company sells for, since 2020.
- Today, Nov 2, 2026
- $2.8B
- Highest close in our data
- $2.9B
- Oct 2026
Nurix Therapeutics is worth $2.8B at the close on Nov 2, 2026, at $25.70 a share.
That is up 197% over the last year and up 85% over five years.
Its highest close in our data was $2.9B in Oct 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2.8B | $1.4B | $2.9B | +89% |
| 2025 | $1.5B | $645.2M | $1.5B | +10% |
| 2024 | $1.4B | $381.2M | $1.9B | +170% |
| 2023 | $500.6M | $213.4M | $598.3M | −3% |
| 2022 | $517.7M | $405.5M | $1.2B | −60% |
| 2021 | $1.3B | $1.1B | $1.8B | +1% |
| 2020 | $1.3B | $901.1M | $1.7B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Nurix Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| NRIXNurix Therapeutics | $2.8B |
| PBHPrestige Consumer Healthcare | $2.4B |
| HRMYHarmony Biosciences | $2.2B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.7B |
| ARQTArcutis Biotherapeutics | $3.9B |
| INDVIndivior Pharmaceuticals | $4.3B |
| ANIPANI Pharmaceuticals | $1.6B |
| PAHCPhibro Animal Health | $1.6B |
| PCRXPacira BioSciences | $1.5B |
| ANABAnaptysbio | $1.4B |
| Peer median | $2.3B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Nurix Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.